Companies / Neurocrine Biosciences Inc / Activity
Activity — Neurocrine Biosciences Inc
18 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | New | Common stock | $11.75M | +89K | 89,184 0.09% of shares | medium |
| Q1 2026 as of | Fuller & Thaler Asset Management, Inc. 13F manager | New | Common stock | $11.51M | +87K | 87,350 0.09% of shares | medium |
| Q1 2026 as of | Brighton Jones LLC 13F manager | New | Common stock | $2.49M | +19K | 18,872 0.02% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common stock | $2.30M | +14K | 13,668 0.01% of shares | low |
| Q1 2025 as of | Ontario Teachers Pension Plan Board 13F manager | New | Common stock | $1.70M | +15K | 15,379 0.02% of shares | low |
| Q2 2026 as of | Sigma Planning Corp 13F manager | New | Common stock | $1.69M | +10K | 10,008 <0.01% of shares | low |
| Q2 2026 as of | Gould Capital, LLC 13F manager | New | Common stock | $1.58M | +9K | 9,390 <0.01% of shares | low |
| Q1 2026 as of | Aureus Asset Management, LLC 13F manager | New | Common stock | $1.25M | +10K | 9,511 <0.01% of shares | low |
| Q1 2026 as of | Sig Brokerage, LP 13F manager | New | Common stock | $778.8K | +6K | 5,912 <0.01% of shares | low |
| Q2 2026 as of | Citizens Financial Group INC/RI 13F manager | New | Common stock | $716.1K | +4K | 4,249 <0.01% of shares | low |
| Q1 2026 as of | Ballentine Partners, LLC 13F manager | New | Common stock | $427.1K | +3K | 3,242 <0.01% of shares | low |
| Q2 2025 as of | Savant Capital, LLC 13F manager | New | Common stock | $302.9K | +2K | 2,410 <0.01% of shares | low |
| Q4 2025 as of | Oxford Asset Management LLP 13F manager | New | Common stock | $298.0K | +2K | 2,101 <0.01% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $269.7K | +2K | 1,600 <0.01% of shares | low |
| Q2 2025 as of | Elevation Point Wealth Partners, LLC 13F manager | New | Common stock | $96.5K | +768 | 768 <0.01% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $74.2K | +440 | 440 <0.01% of shares | low |
| Q3 2023 as of | Leonteq Securities AG 13F manager | New | Common stock | $23.7K | +211 | 211 <0.01% of shares | low |
| Q2 2026 as of | CVA Family Office, LLC 13F manager | New | Common stock | $17.4K | +103 | 103 <0.01% of shares | low |